How does Zepbound work, explained simply

What this guide covers

Zepbound is tirzepatide, a dual GIP and GLP-1 receptor agonist. It mimics two gut hormones to curb appetite, slow the stomach, and steady blood sugar. Here is what that means, step by step, and why two hormones matter. This is patient education, not a substitute for the prescriber who knows your case. Generic names sit next to brand names throughout: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound).

Key points

• The short answer. Zepbound is tirzepatide, a once-weekly injection that works by mimicking two hormones your gut releases after meals, GIP and GLP-1, rather than the single hormone that semaglutide (Ozempic, Wegovy) copies. That is why it is called a dual agonist. Through those two receptors it reduces appetite, slows how fast your stomach empties so you feel full longer, and steadies blood sugar. It is the same molecule as Mounjaro, just labeled for weight management and sleep apnea instead of diabetes. The leading explanation for why tirzepatide's effects tend to be large is that engaging both hormones produces a bigger combined effect than GLP-1 alone. It is not a stimulant or a fat-burner; it is a long-acting copy of two satiety-and-glucose hormones.
• The two hormones it copies. Your gut releases incretin hormones when food arrives, the best-known is GLP-1, but GIP (glucose-dependent insulinotropic polypeptide) is another. Both influence insulin and appetite, though GLP-1's role is better mapped and GIP's is still being worked out. Your own versions of these hormones break down within minutes. Tirzepatide is engineered as a single molecule that activates both receptors and resists breakdown, so one injection delivers a steady dual signal for about a week. Because it copies hormones your body already uses, the appetite changes feel less like fighting hunger and more like the hunger being turned down. The dual-receptor design is the core difference from every semaglutide drug.
• Why two receptors may beat one. The reason tirzepatide is interesting mechanistically is the bet that GIP plus GLP-1 does more together than GLP-1 alone. In the head-to-head SURMOUNT-5 trial, tirzepatide produced greater average weight reduction than semaglutide, and the dual mechanism is the most-cited explanation. The honest framing is that the dual action is real and the outcome difference is real, but exactly how much of the extra benefit comes from the GIP arm specifically is still an open research question; GIP biology in appetite and weight is genuinely less settled than GLP-1. So the truthful version is: two receptors, a measurably larger average effect in the one direct trial, and a mechanism that is well understood on the GLP-1 side and still being mapped on the GIP side.
• Effect one: appetite and 'food noise'. The effect most people notice first is on appetite. The GLP-1 and GIP receptors influence the appetite-regulating centers of the brain, and when Zepbound activates them, most people feel satisfied with noticeably less food and find the constant background pull toward food, often called 'food noise', quieting down. This is the core of how Zepbound supports weight management: it changes the appetite signal rather than relying on willpower. It can feel like a relief and can take some adjusting to, since eating becomes less automatic. The SURMOUNT trials attribute the weight outcomes primarily to this appetite mechanism.
• Effect two: the stomach empties more slowly. Zepbound slows gastric emptying, the rate your stomach passes food into the intestine, which keeps you full longer after meals and supports the appetite effect. It is also the direct cause of most side effects: when the stomach empties slowly, food sits and ferments (nausea, burps, reflux) and transit downstream slows (constipation). This is identical to how semaglutide behaves, the second receptor does not change this part. None of it means the drug is failing; it is the mechanism working. Our nausea and constipation guides cover what genuinely helps, and they apply directly to Zepbound and Mounjaro.

Frequently asked questions